These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 8028751

  • 21. Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer.
    Bonner JA, Sloan JA, Rowland KM, Klee GG, Kugler JW, Mailliard JA, Wiesenfeld M, Krook JE, Maksymiuk AW, Shaw EG, Marks RS, Perez EA.
    Clin Cancer Res; 2000 Feb; 6(2):597-601. PubMed ID: 10690544
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of carcinoembryonic antigen (CEA) and brain-type creatine kinase (CK-BB) in serum from patients with carcinoma of the lung.
    Nikliński J, Furman M, Laudański J, Pałynyczko Z, Welk M.
    Neoplasma; 1991 Feb; 38(2):129-35. PubMed ID: 1645850
    [Abstract] [Full Text] [Related]

  • 23. [Clinical significance of ProGRP31-98 in patients with small-cell lung cancer].
    Yang J, Li R, Li A.
    Zhonghua Zhong Liu Za Zhi; 2000 May; 22(3):216-8. PubMed ID: 11778234
    [Abstract] [Full Text] [Related]

  • 24. CEA is an independent prognostic indicator that is associated with reduced survival and liver metastases in SCLC.
    Yang X, Wang D, Yang Z, Qing Y, Zhang Z, Wang G, Yang Z, Wang Z.
    Cell Biochem Biophys; 2011 Mar; 59(2):113-9. PubMed ID: 20945115
    [Abstract] [Full Text] [Related]

  • 25. Relationship between serum carcinoembryonic antigen level and T status in non-small cell lung cancer.
    Tomita M, Matsuzaki Y, Shimizu T, Hara M, Ayabe T, Onitsuka T.
    Anticancer Res; 2006 Mar; 26(5B):3845-8. PubMed ID: 17094411
    [Abstract] [Full Text] [Related]

  • 26. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R, Fujii S, Ohta M, Nagano Y, Kunisaki C, Yamagishi S, Osada S, Ichikawa Y, Shimada H.
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [Abstract] [Full Text] [Related]

  • 27. The prognostic value of both neuron-specific enolase (NSE) and Cyfra21-1 in small cell lung cancer.
    Ando S, Suzuki M, Yamamoto N, Iida T, Kimura H.
    Anticancer Res; 2004 Dec; 24(3b):1941-6. PubMed ID: 15274381
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
    Hsu WH, Huang CS, Hsu HS, Huang WJ, Lee HC, Huang BS, Huang MH.
    Ann Thorac Surg; 2007 Feb; 83(2):419-24. PubMed ID: 17257963
    [Abstract] [Full Text] [Related]

  • 32. Postoperative serum carcinoembryonic antigen levels in patients with pathologic stage IA nonsmall cell lung carcinoma: subnormal levels as an indicator of favorable prognosis.
    Sawabata N, Maeda H, Yokota S, Takeda S, Koma M, Tokunaga T, Ito M.
    Cancer; 2004 Aug 15; 101(4):803-9. PubMed ID: 15305413
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Expression of CEA and trophoblastic cell markers by lung carcinoma in association with histological characteristics and serum marker levels.
    Slodkowska J, Szturmowicz M, Rudzinski P, Giedronowicz D, Sakowicz A, Androsiuk W, Zakrzewska-Rowinska E.
    Eur J Cancer Prev; 1998 Feb 15; 7(1):51-60. PubMed ID: 9511851
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Evaluation of Cyfra 21-1 as a marker for lung cancer.
    Najemnik C, Mohn-Staudner A, Vetter H, Kokron O, Baumgartner G, Scheiner W, Zwick H, Koderhold G, Alth G, Dudczak R.
    Wien Klin Wochenschr; 1996 Feb 15; 108(15):467-72. PubMed ID: 8806188
    [Abstract] [Full Text] [Related]

  • 37. Markov model and markers of small cell lung cancer: assessing the influence of reversible serum NSE, CYFRA 21-1 and TPS levels on prognosis.
    Boher JM, Pujol JL, Grenier J, Daurès JP.
    Br J Cancer; 1999 Mar 15; 79(9-10):1419-27. PubMed ID: 10188885
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Tumor markers in lung cancer].
    Niho S, Shinkai T.
    Gan To Kagaku Ryoho; 2001 Dec 15; 28(13):2089-93. PubMed ID: 11791391
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.